This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compliance & Legal, Biotech & Pharma

State of the Industry — Critical Bio/Pharma Policy Updates for Compliance After COVID | Covington

Posted by on 04 November 2021
Share this article

Stefanie Doebler, Partner at Covington & Burling LLP, kicked off the Pharmaceutical Compliance Congress (PCC) Hybrid Event in September 2021, with a State of the Industry Spotlight Session focused on critical bio/pharma policy updates for compliance after COVID. The session assessed the current state of bio/pharmaceutical companies post-pandemic, evaluated current healthcare policies and rebate rules impacting the industry, and helped navigate drug pricing transparency and reporting on a state and federal level. Watch the full presentation recording below.

Share this article